Sanofi (SNY) FCF Margin (2009 - 2026)

Sanofi has disclosed FCF Margin across 10 years of filings, most recently posting 25.52% for Q2 2026.

• In Q2 2026, FCF Margin rose 1090.0% year-over-year to 25.52%; the TTM figure through Jun 2026 stood at 39.74% (up 237.0% YoY), while the FY2025 annual figure was 16.53%, up 220.0% from the prior year.
• FCF Margin came in at 25.52% for Q2 2026 at Sanofi, up from 16.01% in the prior quarter.
• In the past five years, FCF Margin ranged from a high of 79.77% in Q4 2023 to a low of 73.43% in Q4 2025.
• Average FCF Margin over 5 years is 22.48%, with a median of 22.6% recorded in 2025.
• Year-over-year, FCF Margin soared 5050 bps in 2023 and sank 12768 bps in 2025.
• Over 5 years, FCF Margin stood at 29.28% in 2022, then surged by 172 bps to 79.77% in 2023, then plunged by 32 bps to 54.24% in 2024, then tumbled by 235 bps to 73.43% in 2025, then soared by 135 bps to 25.52% in 2026.
• Per Business Quant data, the three most recent FCF Margin figures were 25.52% in Q2 2026, 16.01% in Q1 2026, and 73.43% in Q4 2025.